Article
New CRISPR/Cas9-based Fgfr2C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities.
Journal of molecular medicine (Berlin, Germany) - 1 Oct 2024
Yue Ying Ying, Lai Chen-Zhi, Guo Xiao-Shuang, Yang Chang-Sheng, Wang Yu, Song Guo-Dong, Jin Xiao-Lei
Abstract excerpt
Crouzon syndrome (CS), a syndromic craniosynostosis, is a craniofacial developmental deformity caused by mutations in fibroblast growth factor receptor 2 (FGFR2). Previous CS mouse models constructed using traditional gene editing techniques faced issues such as low targeting efficiency, extended lineage cycles, and inconsistent and unstable phenotypes. In this study, a CRISPR/Cas9-mediated strategy was employed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
